## 

|||CONTENTS||
|---|---|---|---|
||||Page|
|Trustees'<br>Report|||1-3|
|Independent<br>Examiner's|Report|||
|Statement of Financial Activities||||
|Balance Sheet||||
|Notes to the Financial Statements|||7-10|
|Schedule of Investments|||11-14|





## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



|||||Unrestricted|fund|
|---|---|---|---|---|---|
||||Note|2023|2022|
|||||f|f|
|Income and endowments:||||||
|Investments:||||||
|Income from investments||||46,254|38,218|
|Total income and endowments||||46,254|38,218|
|Expenditure||||||
|Costs ofraising funds:||||||
|Investment<br>management|fees|||14,540|16,453|
|Expenditure<br>on charitable|activities:|||||
|Direct charitable<br>donations|||5|70,000|30,000|
|Governance<br>costs|||6|7,234|4,812|
|Total expenditure||||90,474|51,265|
|Net expenditure||||(44,220)|(13,047)|
|Other recognised gains/(losses):||||||
|Unrealised<br>gains/(losses)|on revaluation|||(50,395)|107,663|
|Realised gains/(losses)<br>on|disposals|||1,050|6,333|
|Net gains/(losses)<br>on investment||assets||(49,345)|113,996|
|Net movement<br>in funds||||(94,865)|100,949|
|Reconciliation<br>of'funds||||||
|Funds brought<br>forward|||9|2,347,811|2,246,862|
|Funds carried forward|||9|2,252,946|2,347,811|





## 




## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

|Income from|Income from|investments|||||||2023|2022|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||f|f|
|Investments||listed<br>on|a|recognised||stock|exchange|or|||
|consisting|of|collective investments:|||||||||
|Dividends|||||||||37,011|31,068|
|Dividends|from overseas||companies||and|unit|trusts||9,243|7,150|
||||||||||46,254|38,218|





## 

|5.|Direct charitable<br>institutional|Direct charitable<br>institutional|grants|grants||||||
|---|---|---|---|---|---|---|---|---|---|
||The following grants were made|||in the year.||||||
|||||||||2023|2022|
|||||||||f|f|
||Silsden Aid ln Sickness|Fund (Registered|||Charity:||No 236399)|70,000|30,000|
|||||||||70,000|30,000|
|6.|Governance<br>costs|||||||||
|||||||||2023|2022|
|||||||||f|f|
||Legal and professional|fees (note 10)||||||5,934|3,678|
||Accountancy<br>and Independent|||Examination||(note 3)||1,300|1,134|
|||||||||7,234|4,812|
|7.|Investments|||||||2023<br>f|2022<br>f|
||Market value brought|forward||||||2,357,935|2,256,012|
||Add: additions to investments|||at cost||||152,699|96,908|
||Less: opening<br>cash|||||||(169,675)|(167,692)|
||Disposals at carrying|value||||||(200,174)|(104,631)|
||Unrealised<br>gain/(loss)|on revaluation||||||(50,395)|107,663|
||Cash awaiting<br>re-investment|||||||168,392|169,675|
||Market value carried|forward||||||2p258,782|2,357,935|
||At historic cost at 5 April|||||||1,801,946|1,754,541|





|||2023|2022|
|---|---|---|---|
|||f|E|
|UK equities||1,667,290|1,720,540|
|Overseas equities||423,100|467,720|
|Cash awaiting|re-investment|168,392|169,675|
|||2,258,782|2,357,935|



## 

|Accruals||||||2023|2022|
|---|---|---|---|---|---|---|---|
|||||||f|f|
|Investment||portfolio management|||fees|0|4,400|
|Accountancy|||and independent|examination||1,300|1,140|
|Wrigleys|law||advice|||4,536|4,920|
|||||||5,836|10,460|



## 

## 

## 

## 

##